| |
|
 |
Huadong Medicine Co., Ltd. was founded in March, 1993, based on the medicine distribution network in Hanzhou, capital of Zhejiang province, after a government-oriented restructuring. On December 22, 1999, the company went public on the Shenzhen Stock Exchange and raised around CNY288 million through issuing 5,000 shares. Its main business covers the production and sale of chemical medicine and traditional Chinese medicine.
Structure of Main Business Revenue of Huadong Medicine
(Unit: CNY billion)
Source: ResearchInChina
Huadong Medicine's main business revenue covers two parts-pharmacy industry and pharmacy business. Since the gross profit margin of pharmacy industry is much higher than the pharmacy business, Huadong Medicine has been making vigorous efforts to open up the market of the pharmacy industry, which has made the proportion of its pharmacy industry to the total main business revenue increase year by year. This is one of the key reasons that the company's performance rose gradually in the recently years.
According to the company's announcement on April 3, 2008, Huadong Medicine plans to acquire 78.87% stake in Xi'an Bohua Pharmaceutical Co., Ltd. and 65% stake in the latter's subsidiary named Shaanxi Jiuzhou Medicine Co., Ltd. for CNY98 million. The acquisition, if done, will not only help the company reinforce its strength in special pharmaceutical raw materials, but also enter the narcotic market with high barriers to enter.
|
|
|
|
|
If this report could not still meet your requirement, or
you have any comments or suggestions on it, please leave a
message to us.
|
2005-2007 www.researchinchina.com All Rights Reserved
| |
|
|
| |
|
Huadong Medicine Co., Ltd. was founded in March, 1993, based on the medicine distribution network in Hanzhou, capital of Zhejiang province, after a government-oriented restructuring. On December 22, 1999, the company went public on the Shenzhen Stock Exchange and raised around CNY288 million through issuing 5,000 shares. Its main business covers the production and sale of chemical medicine and traditional Chinese medicine.
Structure of Main Business Revenue of Huadong Medicine
(Unit: CNY billion)
Source: ResearchInChina
Huadong Medicine's main business revenue covers two parts-pharmacy industry and pharmacy business. Since the gross profit margin of pharmacy industry is much higher than the pharmacy business, Huadong Medicine has been making vigorous efforts to open up the market of the pharmacy industry, which has made the proportion of its pharmacy industry to the total main business revenue increase year by year. This is one of the key reasons that the company's performance rose gradually in the recently years.
According to the company's announcement on April 3, 2008, Huadong Medicine plans to acquire 78.87% stake in Xi'an Bohua Pharmaceutical Co., Ltd. and 65% stake in the latter's subsidiary named Shaanxi Jiuzhou Medicine Co., Ltd. for CNY98 million. The acquisition, if done, will not only help the company reinforce its strength in special pharmaceutical raw materials, but also enter the narcotic market with high barriers to enter.
|
|
|
|
|
2005-2006 www.researchinchina.com All Rights Reserved |
|
| |
|
 |
| |
|
1. Huadong Medicine Company Profile
1.1 Brief Introduction
1.2 Shareholders of Huadong Medicine
1.3 Pharmacy Policies
1.3.1 Hospital to Follow the Measures for Prescription Management
1.3.2 Industry Concentration to Be Lifted Greatly by Improved Environment Protection Standards2. Main Business of Huadong Medicine
2.1 Products
2.2 Pharmacy Industry
2.2.1 Immunosuppressant Products
2.2.2 Diabetes Medicines
2.2.3 Anti-peptic ulcer medicine
2.2.4 Pharmaceutical Raw Material
2.2.5 Summery on Pharmacy Industry
2.3 Pharmacy Business
2.4 Marketing and Development Strategies
2.4.1 Marketing Strategy
2.4.2 Development Strategy 3. Financial Status of Huadong Medicine Co., LTD
3.1 Solvency
3.2 Operation Efficiency
3.3 Profitability
3.4 Growing Ability
3.5 Financial Structure
3.6 Cash Flow Ratio 4. SWOT Analysis
4.1 Strength
4.2 Weakness
4.3 Opportunities
4.4 Threats 5. Summarization
|
|
|
|
|
2005-2006 www.researchinchina.com All Rights Reserved |
|
| |
|
 |
| |
|
Huadong Medicine's Shareholding Structure
Huadong Medicine's Organization Structure
Huadong Medicine's Top Ten Shareholders As of 2007
Huadong Medicine's Main Products
Huadong Medicine's Main Businesses, 2003-2007
Huadong Medicine's Business Structure in 2007
Huadong Medicine's Gross Profit Margin, 2003-2007
Companies Producing Main Products of Huadong Medicine
Huadong Medicine's Sales Revenue by Product, 2007
Huadong Medicine's Sales Revenue of Main Products
Huadong Medicine's Pharmacy Industry Performance, 1998-2007
Huadong Medicine's Distribution Targets in 2006
Development Thought of the Western Medicine Sector
Huadong Medicine's Sales Revenue and Growth by Product, 2004-2008
Distribution of China Immunosuppressant Market Share
Purchasing Value of Sampled Immunosuppressant in Typical Cities of China
Growth Rate of Sampled Immunosuppressant in Typical Cities of China
Four Families in Cyclosporine Market
Immunosuppressant Markets in the U.S. and China
China Diabetes Market Scale and Its Growth, 2002-2006
Market Shares of Sampled Diabetes Medicines, 2005-2006
Market Shares of Pioglitazone Producers in 16 Chinese Sampled Cities
Top Ten Diabetes Medicine Producers in China, 2004-2006
Huadong Medicine's Revenue, Growth Rate and Profit Margin from Diabetes and Peptic Medicine, 2004-2008
Main Peptic Ulcer Drugs Applied in Clinic in China and their Market Shares
Proton Pump Inhibitor Main Products and Market Shares, 2004-2006
Pantoprazole Market Share and Growth, 2004-2006
Competition among Pantoprazole Producers
Competition among Omeprazole Producers
Huadong Medicine's Sales Revenue and Growth Rate, 2004-2008
Huadong Medicine's Specific Quality Standards for Bulk Raw Material Purchasing
Growth of Huadong Medicine's Business 1998-2007
Huadong Medicine's Distribution Network
Huadong Medicine's Production, Sales, and Technical Team, 2006-2007
Products of General Agents above Designated Scale, 2005-2007
Ornidazole Applied for Gynecological Inflammation Disease, 2004-2006
Market Shares of Ornidazole
Huadong Medicine's Solvency
Huadong Medicine's Operation Efficiency
Huadong Medicine's Profitability
Huadong Medicine's Growing Ability
Huadong Medicine's Financial Structure
Huadong Medicine's Cash Flows
|
2005-2008 www.researchinchina.com All Rights Reserved
|
